Ppt for Carcinoembryonic Antigen (CEA) Market: Global Market Insights, Inc.

1
Carcinoembryonic Antigen (CEA) Market 2016
2023
2
Global Market Scenario of Carcinoembryonic
Antigen (CEA)

• Carcinoembryonic antigen (CEA) market size was
  valued at USD 1.67 billion in 2015, with forecast
  target exceeding USD 2.8 billion by 2023, at over
  6.6 CAGR.
• Rising incidences of cancer especially colorectal
  cancer is one of the key factors attributing to
  the growth of the CEA market size in the coming
  years. 
• WHO has estimated cancer incidences (cases per
  year) in 2012 to be nearly 14.1 million globally,
  of which 7.4 million were male and 6.7 million
  were female patients. 
• In addition to this, due to aging population,
  incidence rate for cancer are estimated to be
  nearly 205 new cancer cases for every 100,000
  men, and 165 for every 100,000 females globally.
• https//www.gminsights.com/industry-analysis/carci
  noembryonic-antigen-cea-market

3
Continue.....

• The geriatric population is the potential patient
  pool for cancer it is expected to boost usage
  rates for carcinoembryonic antigen market
  throughout the forecast timeframe.
• According to United Nations data, global
  geriatric population is expected to more than
  double by 2050 to reach an estimated population
  of over 2,000 million from 809.4 million in 2012.
• Favorable government initiatives aimed at
  improving diagnostic rates and the development of
  novel combination biomarkers are expected to
  present the CEA market with future growth
  opportunities.
• The industry is also witnessing increasing
  prevalence of Ovarian Cancer. According to the
  data published by World Cancer Research Fund
  International (WCRFI), it has been estimated that
  in 2012, ovarian cancer is the seventh most
  prevalent cancer in women and eighteenth most
  common cancer overall
• https//www.gminsights.com/industry-analysis/carci
  noembryonic-antigen-cea-market

4
North America carcinoembryonic antigen market
size, by application, 2014-2023 (USD Million)

https//www.gminsights.com/industry-analysis/carci
noembryonic-antigen-cea-market
5
360 Analysis

• Application Analysis
• Colorectal cancer is the predominant market
  segment in 2016, with 42 of the global
  carcinoembryonic antigen market share, owing to a
  significantly large patient pool becoming prone
  to cancer due to consumption of fatty foods,
  alcohol, and exposure to carcinogenic elements.
   
• Regional Analysis
• North America, driven by the U.S CEA market size,
  is targeted to exceed USD 800 million in 2016,
  making it the largest regional market.
• In 2012, China accounted for 3.07 million newly
  diagnosed cases (WHO Report).  
• Competitive Market Share
• Global carcinoembryonic antigen market share is
  garnered by number large and small companies. The
  top players in this market include Roche
  Diagnostics, Quest Diagnostics, Abbott
  Diagnostics, and GenWay Biotech, Inc. among
  others. New product launch in response to growing
  demand for minimally invasive procedures, and
  early detection methods is major strategy adopted
  by the players in this market, in order to
  maintain leadership position. 

6

Latest Research Report On Carcinoembryonic
antigen (CEA) Market _at_ https//www.gminsights.com/
industry-analysis/carcinoembryonic-antigen-cea-mar
ket Download Latest Report PDF _at_
https//www.gminsights.com/request-sample/detail/4
27
7
Stay In Touch You can visit us at
www.gminsights.com